- Increasing raw material and other costs.
- Increased competition from India and China in clinical chemistry.
- Declining sales and increased technical challenges in STAT-Site M β-HB serum and plasma product line.
- Reduced revenues from Russia due to increased sanctions.
- Impact of sanctions and Russian Government retaliation on Russian operations.
EKF Diagnostics Holdings plc
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, EKF Diagnostics Holdings plc disclosed greenhouse gas emissions of 473 tCO2e/year (Group). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
473 tCO2e/year (Group)
2023
Energy Use
1.8M Kwh/year (Group)
2023
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2023 | 473 tCO2e/year (Group) |
| 2022 | 338.0K tCO2e/year |
| 2021 | 15 tCO2e (UK only) |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Reduced carbon emissions per £m of turnover to 0.18 tonnes of CO2 (2022: 0.19 tonnes of CO2). Improved energy efficiency by reducing electricity usage through lower wastage and promoting video conferencing.
🎯 Climate & Sustainability Targets
🔜 Short-term
- Continue to implement strategies to grow Point-of-Care and Life Sciences and to concentrate on core products and services within each of the divisions to drive further margin improvement and enhance cash generation.
📅 Medium-term
- Scale up output for fermentation customers and add additional customers. Aiming to have South Bend site running at closer to optimal capacity by early 2026.
🌱 ESG Focus Areas
Climate ChangeEmployee WellbeingCorporate Social Responsibility